NTRK fusion gene EQA

Posted 21/04/2020

Today NICE has recommended VITRAKVI® (larotrectinib) for the treatment of advanced neurotrophic tyrosine receptor kinase (NTRK) fusion-positive solid tumours in adult and paediatric patients in England.  Ensure your NTRK test quality with our EQA!

AstraZeneca Sponsorship of cfDNA testing for EGFR mutations in Lung Cancer EQA

Posted 1/04/2020

We are delighted to announce that AstraZeneca have agreed to fund laboratory participation in the EQA through the provision of an unrestricted educational grant. Participation will in the EQA will therefore be FREE.

If you have already registered for the EQA then we will credit your account to ensure that participation costs are withdrawn.  If you have NOT registered, please log in to your account and enrol for the scheme. The closing date has been extended to 30th April 2020.

Capacity is capped at 300 laboratories and we only less than 100 spaces left so please register quickly if you want to guarantee your place on the EQA.

EQA changes due to COVID-19

Posted 19/03/2020

Please go to www.genqa.org/covid19 for all our latest updates.

Tissue-i Histopathology Tumour Assessment

Posted 18/03/2020

Don't forget to register for our latest Histopathology tumour assessment.  Closing date for registration is 30th April 2020.

Coronavirus (COVID-19) updates

Posted 18/03/2020

For all GenQA updates related to COVID-19 impact, please go to https://www.genqa.org/covid19

Royal College of Pathologists advert

Posted 9/03/2020


The College has set up a new pathology wide External Quality Assurance (EQA) review programme to improve the governance and culture of pathology Quality Assurance (QA). We are looking for experienced professionals with experience in technical EQA to join our workstreams.

For more details or to apply please go tohttps://www.rcpath.org/discover-pathology/news/tbc.html

NEW EQA for 2020: HRR testing for patients with prostate cancer

Posted 5/03/2020

For full details of this EQA see HERE

To register, please click to complete the Online Registration Form.  Please note that places are limited to 30 participants only.

2019 Participant Survey with GenQA response

Posted 2/03/2020

Please find the results from our 2019 Participants Survey HERE.  
GenQA would like to thank all the participants who took the time to complete the survey.  If you would like specific feedback to individual comments or have further comment, then please contact us at info@genqa.org. 

NEW - cfDNA testing for EGFR mutations in Lung cancer EQA

Posted 26/02/2020

For full details of this EQA click HERE


Go to top